3.8 Article

Radiation Management for Breast Cancer After Neoadjuvant Therapy

期刊

CURRENT BREAST CANCER REPORTS
卷 -, 期 -, 页码 -

出版社

SPRINGER
DOI: 10.1007/s12609-023-00506-1

关键词

Neoadjuvant chemotherapy; Breast cancer; Radiation; Regional nodal irradiation; Radiation omission

类别

向作者/读者索取更多资源

Personalizing adjuvant radiotherapy based on response to neoadjuvant chemotherapy is a goal that is currently being evaluated in multiple clinical trials, including NSABP B-51.
Purpose of ReviewNeoadjuvant chemotherapy (NAC) utilization is an important part of breast cancer therapy. Recent advances call into question the optimal role of radiotherapy after NAC, as many radiation studies were performed without NAC. This review was conducted to understand the current data, outstanding questions and ongoing trials related to radiotherapy after NAC.Recent FindingsResponse to NAC is associated with promising clinical outcomes, particularly in triple-negative and HER2+ breast cancer. Retrospective data suggest that modification of radiotherapy based on tumor response to NAC may be appropriate, though caution is advised without prospective randomized evidence. NSABP B-51 and Alliance A011202 will investigate the management of nodal disease in this setting. Future trials will examine the optimal sequencing of treatments.SummaryThe personalization of adjuvant radiotherapy based on response to neoadjuvant chemotherapy is an attractive goal that is currently being evaluated in multiple clinical trials, including NSABP B-51.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据